These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5034813)

  • 81. Identification of dekamycin antibiotics.
    Van TD; Khac DD; Fetizon M; Tabet JC; Le Beyec Y; Quyen TC
    J Chromatogr; 1988 May; 440():71-85. PubMed ID: 3403673
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Metabolic products of microorganisms. 243. Pyridazomycin, a new antifungal antibiotic produced by Streptomyces violaceoniger.
    Grote R; Chen Y; Zeeck A; Chen ZX; Zähner H; Mischnick-Lübbecke P; König WA
    J Antibiot (Tokyo); 1988 May; 41(5):595-601. PubMed ID: 3384747
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synthetic approaches to N(delta)-methylated L-arginine, N(omega)-hydroxy-L-arginine, L-citrulline, and N(delta)-cyano-L-ornithine.
    Schade D; Töpker-Lehmann K; Kotthaus J; Clement B
    J Org Chem; 2008 Feb; 73(3):1025-30. PubMed ID: 18179234
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Restoration of aerial mycelium and antibiotic production in a Streptomyces griseoflavus arginine auxotroph.
    Ochi K; Saito Y; Umehara K; Ueda I; Kohsaka M
    J Gen Microbiol; 1984 Aug; 130(8):2007-13. PubMed ID: 6470674
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
    Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1130-40. PubMed ID: 1955396
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Aspiculamycin, a new cytosine nucleoside antibiotic. I. Producing organism, fermentation and isolation.
    Arai M; Haneishi T; Enokita R; Kayamori H
    J Antibiot (Tokyo); 1974 May; 27(5):329-33. PubMed ID: 4850654
    [No Abstract]   [Full Text] [Related]  

  • 87. Novel naphthoquinones from a Streptomyces sp.
    Kulanthaivel P; Perun TJ; Belvo MD; Strobel RJ; Paul DC; Williams DC
    J Antibiot (Tokyo); 1999 Mar; 52(3):256-62. PubMed ID: 10348040
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Macrolides of the bafilomycin family produced by Streptomyces sp. CS.
    Li J; Lu C; Shen Y
    J Antibiot (Tokyo); 2010 Oct; 63(10):595-9. PubMed ID: 20823894
    [TBL] [Abstract][Full Text] [Related]  

  • 89. AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp.
    Sato S; Kajiura T; Noguchi M; Takehana K; Kobayashi T; Tsuji T
    J Antibiot (Tokyo); 2001 Jan; 54(1):102-4. PubMed ID: 11269707
    [No Abstract]   [Full Text] [Related]  

  • 90. Chrymutasins: novel-aglycone antitumor antibiotics from a mutant of Streptomyces chartreusis. II. Characterization and structural elucidation.
    Uchida H; Nakakita Y; Enoki N; Abe N; Nakamura T; Munekata M
    J Antibiot (Tokyo); 1994 Jun; 47(6):655-67. PubMed ID: 8040070
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Antimetabolites produced by microorganisms. 3. 2-aminopurine-6-thiol (thioguanine).
    Scannel JP; Pruess DL; Kellett M; Demny TC; Stempel A
    J Antibiot (Tokyo); 1971 May; 24(5):328-9. PubMed ID: 4931964
    [No Abstract]   [Full Text] [Related]  

  • 92. Structural insights into the substrate-bound condensation domains of non-ribosomal peptide synthetase AmbB.
    Chu Yuan Kee MJ; Bharath SR; Wee S; Bowler MW; Gunaratne J; Pan S; Zhang L; Song H
    Sci Rep; 2022 Mar; 12(1):5353. PubMed ID: 35354859
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.
    Moncada S; Rees DD; Schulz R; Palmer RM
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2166-70. PubMed ID: 1848694
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
    Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
    Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Kinetic characteristics of nitric oxide synthase from rat brain.
    Knowles RG; Palacios M; Palmer RM; Moncada S
    Biochem J; 1990 Jul; 269(1):207-10. PubMed ID: 1695842
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antimetabolites produced by microorganisms. VI. L-N 5 -(1-iminoethyl) ornithine.
    Scannell JP; Ax HA; Pruess DL; Williams T; Demny TC
    J Antibiot (Tokyo); 1972 Mar; 25(3):179-84. PubMed ID: 5034813
    [No Abstract]   [Full Text] [Related]  

  • 97. Antimetabolites produced by microorganisms. II. L-2-amino-4-pentynoic acid.
    Scannell JP; Pruess DL; Demny TC; Weiss F; Williams T
    J Antibiot (Tokyo); 1971 Apr; 24(4):239-44. PubMed ID: 4995438
    [No Abstract]   [Full Text] [Related]  

  • 98. Antimetabolites produced by microorganisms. X. L-2-amino-4-(2-aminoethoxy)-trans-3-butenoic acid.
    Pruess DL; Scannell JP; Kellett M; Ax HA; Janecek J; Williams TH; Stempel A; Berger J
    J Antibiot (Tokyo); 1974 Apr; 27(4):229-33. PubMed ID: 4850608
    [No Abstract]   [Full Text] [Related]  

  • 99. Antimetabolites produced by microorganisms. IX. Chemical synthesis of N5-hydroxyornithine and N5-hydroxyarginine.
    Maehr H; Leach M
    J Org Chem; 1974 Apr; 39(8):1166-8. PubMed ID: 4847775
    [No Abstract]   [Full Text] [Related]  

  • 100. L-3-(2,5-dihydrophenyl)alanine, an antimetabolite of L-phenylalanine produced by a streptomycete.
    Scannell JP; Pruess DL; Demny TC; Williams T; Stempel A
    Jpn J Antibiot; 1970 Dec; 23(6):618-9. PubMed ID: 5312767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.